BILBAO, Spain--(BUSINESS WIRE)--Jul 3, 2025--
H2SITE has been awarded the EIC (European Innovation Council) Accelerator program for a project aimed at deploying a first-of-its-kind ammonia cracking unit capable of producing 1 ton of high-purity hydrogen per day. The system is based on H2SITE’s proprietary palladium-based membrane reactor technology, which enables the simultaneous catalytic decomposition of ammonia and selective hydrogen separation within a single unit.
Click to Gallery
H2SITE Membrane Reactor Technology
Ammonia Cracker using Membrane Reactor Technology
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702142283/en/
This breakthrough technology offers several compelling advantages over conventional ammonia cracking processes:
The ammonia cracking system will serve as a demonstration plant, aiming to validate the commercial and operational readiness of H2SITE’s integrated membrane reactor approach at an industrially relevant scale, with the goal of advancing the decarbonization of hard-to-abate sectors.
“This project represents an important milestone for the development of our technology. It enables the next steps toward commercializing our units for industrial sectors, energy hubs (such as ports and large-scale distribution centers), and onboard maritime applications," said Andres Galnares, CEO of H2SITE.
As the hydrogen economy develops, efficient solutions for transporting low-carbon hydrogen are essential. Ammonia is a promising hydrogen carrier due to its high volumetric energy density and existing infrastructure, and more than 20 million tons of ammonia are transported by ship every year. Advances in ammonia cracking technology such as H2SITE’s integrated membrane reactor will be an enabler to making this pathway competitive, enabling large-scale, flexible hydrogen supply chains.
About H2SITE
H2SITE, founded in 2020, is a technology company specializing in the on-site production and separation of high-purity hydrogen. The company utilizes exclusive palladium-alloy membrane reactor technology to efficiently convert various feedstocks including ammonia, methanol, and syngas into hydrogen. Additionally, H2SITE enables the separation of hydrogen from low-concentration gaseous mixtures for applications such as salt caverns or geologic hydrogen. By decentralizing hydrogen production through innovative ammonia cracking and separation solutions, H2SITE addresses the challenges of cost-effective hydrogen transportation and storage, significantly reducing associated costs and emissions.
( www.h2site.com )
H2SITE Membrane Reactor Technology
The H2SITE Team
Ammonia Cracker using Membrane Reactor Technology
LONDON (AP) — King Charles III has been “deeply touched” by the response to his update on his cancer treatment, Buckingham Palace said Saturday, adding that the monarch is pleased to have highlighted the value of screening programs for the disease.
Medics and health charities have praised the king for his openness, saying his statement on Friday had already prompted people to seek information about cancer.
In a strikingly personal video statement, the British monarch acknowledged that a cancer diagnosis can feel “overwhelming,” but said catching the disease early brings “the precious gift of hope.”
Here’s what to know about the king's condition and his message.
The 77-year-old king said in a statement broadcast Friday that his treatment schedule will be reduced in the new year, “thanks to early diagnosis, effective intervention and adherence to ‘doctors’ orders.’”
He encouraged others to take advantage of screening programs such as those for breast, bowel and cervical cancer offered by Britain’s public health service.
“Early diagnosis quite simply saves lives,” the king said in the statement aired during a “Stand Up to Cancer” telethon on TV station Channel 4. He said catching the disease early had allowed him “to continue leading a full and active life even while undergoing treatment.”
Charles has received outpatient treatment for almost two years. Buckingham Palace did not say the king is in remission, but that his treatment is moving to a “precautionary phase” and his condition will be monitored to ensure his continued recovery.
“I know from my own experience that a cancer diagnosis can feel overwhelming,” the king said in his video statement. “Yet I also know that early detection is the key that can transform treatment journeys, giving invaluable time to medical teams – and, to their patients, the precious gift of hope.”
Charles announced in February 2024 that he had been diagnosed with cancer, and, in a break from centuries of secrecy about royal health, he has since spoken about the illness, using his story to promote cancer awareness and treatment.
The openness has limits, though. The king has not disclosed what type of cancer he has or what kind of treatment he is receiving. The palace said it was an intentional decision designed to ensure his message reaches the widest possible audience.
The king’s cancer was discovered after treatment for an enlarged prostate. While doctors ruled out prostate cancer, tests revealed “a separate issue of concern,” palace officials said last year.
Charles suspended his public appearances for about two months after his diagnosis. Since returning to the public eye, he has visited cancer treatment centers across the country and shared stories with fellow patients.
Buckingham Palace said Charles “will be greatly encouraged and deeply touched by the very positive reaction" his message has generated. “He will be particularly pleased at the way it has helped to shine a light on the benefits of cancer screening programs,” it added.
British cancer charities said the number of people seeking information about cancer jumped after the king revealed he was undergoing treatment last year.
Cancer Research U.K. said about 100,000 people have visited its Screening Checker website since it was launched on Dec. 5, most of them since the king’s statement on Friday.
The charity's Chief Executive Michelle Mitchell said: “When public figures speak openly about their cancer diagnosis, it can prompt others to check in on their health.”
Broadcaster Jonathan Dimbleby, the king’s authorized biographer, said the statement was “a remarkable thing for a monarch to do.”
“It takes guts, and the fact that he came out and did that will save lives,’” Dimbleby said.
The Princess of Wales, who announced her own cancer diagnosis six weeks after her father-in-law, has also given updates on her treatment. Kate announced in January that her cancer is in remission.
Find more of AP’s coverage at https://apnews.com/hub/royalty
Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)
Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)
